1 active not recruiting, 1 recruiting, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Metastatic HER2 Negative Breast Carcinoma: new trials by email Literature Review of Metastatic HER2 Negative Breast Carcinoma trials Research Report on Metastatic HER2 Negative Breast Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases UTD1 combined with capecitabine - Metastatic HER2 Negative Breast Carcinoma, Brain Metastases | Phase 1 / Phase 2 | Recruiting | Hunan Cancer Hospital | 30 | 2023-01-01 | 2025-04-25 |
| Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases Sacituzumab Govitecan - Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma | Phase 2 | Active not recruiting | SWOG Cancer Research Network | 44 | 2021-06-08 | 2026-05-06 |
| Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer Abexinostat Tosylate, Fulvestrant, Palbociclib - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 1 | Withdrawn | Pamela Munster | 2021-03-31 | 2021-05-18 |
Brain Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Endometrioid (1) · Fallopian Tube Neoplasms (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1)
Neoplasms (3) · Neoplasms by Site (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Central Nervous System Neoplasms (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Adenocarcinoma (1) · Adnexal Diseases (1) · Breast Diseases (1) · Carcinoma (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Endometrial Neoplasms (1) · Fallopian Tube Diseases (1)
Capecitabine (1) · Fulvestrant (1) · palbociclib (1) · sacituzumab govitecan (1)
Hunan Cancer Hospital (1) · Pamela Munster (1) · SWOG Cancer Research Network (1)
China (1) · United States (1)
Andrew J Brenner (1) · Pamela N Munster, MD (1)
U10CA180888 (1)